Yarrow Bioscience, Inc. (YARW)
NASDAQ: YARW · Real-Time Price · USD
41.52
+0.12 (0.29%)
At close: Aug 18, 2026, 4:00 PM EDT
41.52
0.00 (0.00%)
After-hours: Aug 18, 2026, 4:10 PM EDT
Yarrow Bioscience Employees
Yarrow Bioscience had 6 employees as of March 31, 2026. The number of employees decreased by 1 or -14.29% since the number was last reported on December 31, 2025.
Employees
6
Change
-1
Growth
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$47,329,333
Market Cap
116.26M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 6 | -1 | -14.29% |
| Dec 31, 2025 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Nautilus Biotechnology | 127 |
| Seer, Inc. | 124 |
| Inovio Pharmaceuticals | 112 |
| enGene Therapeutics | 82 |
| Vivani Medical | 42 |
| Genelux | 26 |
| Black Diamond Therapeutics | 21 |
| Coya Therapeutics | 8 |
YARW News
- 1 day ago - Yarrow Bioscience reported Q2 EPS ($2.14) - TheFly
- 5 days ago - Yarrow Bioscience Reports Second Quarter 2026 Financial Results and Provides Business Update - Business Wire
- 15 days ago - Yarrow Bioscience initiated with a Buy at BTIG - TheFly
- 21 days ago - Yarrow Bioscience initiated with a Buy at TD Cowen - TheFly
- 22 days ago - Yarrow Bioscience Announces Closing of Merger with VYNE Therapeutics and Initiation of Dosing in Phase 2a/2b Trial of YB-101, a Potential First-in-Class Treatment for Graves' Disease and Thyroid Eye Disease - Business Wire
- 26 days ago - VYNE Therapeutics Provides Update Regarding Cash Dividend, Reverse Stock Split and Anticipated Timing of Closing of the Proposed Merger with Yarrow Bioscience - GlobeNewsWire
- 4 weeks ago - VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience - GlobeNewsWire
- 5 weeks ago - VYNE Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Yarrow Bioscience - GlobeNewsWire